Enbio PRO
Enbio Group AG · Decision date Feb 26, 2026
What did the FDA decide?
FDA records K260254 as a 510(k) premarket notification, with a decision dated Feb 26, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- General Hospital
- Decision date
- Feb 26, 2026
Regulatory record facts
- Identifier
- K260254
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Enbio Group AG
- Product code
- FLE
- Decision code
- SESE
- Decision date
- Feb 26, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Sterilizer, Steam.
- Applicant
- Enbio Group AG
- Product code
- FLE
- FDA device class
- 2
FDA decision timeline
K260254 received
Application receipt date recorded by FDA.
K260254 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code FLE
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Foster Plus-22L (SNK/CE-F22)K260354 | Zhejiang Fomos Medical Technology Co., Ltd. | 510(k) clearance | Oct 30, 2026 | FDA |
AMSCO 700 Steam SterilizerK261055 | STERIS CORPORATION | 510(k) clearance | Jun 24, 2026 | FDA |
| Maquet GmbH (A Getinge Group Company) | 510(k) clearance | Jan 22, 2026 | FDA | |
| Lucas Lifecare | 510(k) clearance | Dec 30, 2025 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Enbio Group AG
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Oensingen
Sources and methodology
- Original FDA record: K260254
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records
